The Myeloma Beacon » Genasense (oblimersen, G3139)

Genasense (oblimersen, G3139)

By: Admin; Published: October 15, 2008 @ 8:00 am | Comments Disabled

Brand Name:	Genasense
Generic Name:	oblimersen
Code Name:	G3139
Company:	Genta, Inc. & Aventis
FDA Clinical Phase:	3

Description:

Genasense is a type of antisense oligodeoxyribonucleotide. It may kill cancer cells by blocking the production of a protein that makes cancer cells live longer and by making them more sensitive to anticancer drugs.

Clinical Trials:
For a list of clinical trials studying Genasense for the treatment of multiple myeloma, see ClinicalTrials.gov ^[1].

Official website for Genasense: http://www.genta.com/genasense/ ^[2]

Source: NCI Cancer Glossary, Genasense, http://www.cancer.gov/templates/db_alpha.aspx?searchTxt=Genasense ^[3] (as of November 14, 2009)

Article printed from The Myeloma Beacon: https://myelomabeacon.org

URL to article: https://myelomabeacon.org/resources/2008/10/15/genasense/

URLs in this post:

[1] ClinicalTrials.gov: http://www.clinicaltrial.gov/ct2/results?term=&recr=&rslt=&type=&cond=multiple+myeloma&intr=Genasense&outc=&lead=&spons=&id=&state1=&cntry1=&state2=&cntry2=&state3=&cntry3=&locn=&gndr=&rcv_s=&rcv_e=&lup_s=&lup_e=

[2] http://www.genta.com/genasense/: http://www.genta.com/genasense/

[3] http://www.cancer.gov/templates/db_alpha.aspx?searchTxt=Genasense: http://www.cancer.gov/templates/db_alpha.aspx?searchTxt=Genasense

Click here to print.